Anuh Pharma Ltd. - Research Center
506260 ANUHPHR Group (B) BSE data
Results
Statement
More
| Mar ' 25 |
Mar ' 24 |
Mar ' 23 |
Mar ' 22 |
Mar ' 21 |
Equity share capital
| 25.06 |
25.06 |
25.06 |
25.06 |
25.06 |
Share application money
Preference share capital
Reserves & surplus
| 300.97 |
266.16 |
216.17 |
188.72 |
165.59 |
Secured loans
Unsecured loans
Total
| 336.52 |
293.23 |
241.22 |
216.88 |
204.24 |
Gross block
| 119.00 |
103.42 |
99.53 |
98.57 |
97.17 |
Less : revaluation reserve
Less : accumulated depreciation
| 60.78 |
54.47 |
46.72 |
37.15 |
25.75 |
Net block
| 58.21 |
48.95 |
52.81 |
61.42 |
71.42 |
Capital work-in-progress
Investments
| 105.81 |
96.77 |
90.83 |
42.68 |
31.39 |
Current assets, loans & advances
| 342.33 |
299.51 |
261.34 |
242.97 |
229.83 |
Less : current liabilities & provisions
| 170.10 |
152.45 |
163.76 |
130.29 |
128.40 |
Total net current assets
| 172.22 |
147.06 |
97.58 |
112.68 |
101.43 |
Miscellaneous expenses not written
Total
| 336.52 |
293.23 |
241.22 |
216.88 |
204.24 |
Book value of unquoted investments
| 52.36 |
53.82 |
89.03 |
40.87 |
29.58 |
Market value of quoted investments
Contingent liabilities
| 25.26 |
20.29 |
30.33 |
32.92 |
23.39 |
Number of equity sharesoutstanding (Lacs)
| 501.12 |
501.12 |
501.12 |
501.12 |
501.12 |